Novel lactoferrampin antimicrobial peptides derived from human lactoferrin

Biochimie

Volumn 91, Issue 1, 2009, Pages 141-154

  Haney, Evan F ^a   Nazmi, Kamran ^b   Lau, Fanny ^a   Bolscher, Jan G M ^b   Vogel, Hans J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Antimicrobial peptide; Human lactoferrin; Lactoferrampin; Micelle bound peptide structure; Nuclear magnetic resonance

Indexed keywords

LACTOFERRAMPIN; LACTOFERRIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; FLUORESCENCE SPECTROSCOPY; HEMOLYSIS; NONHUMAN; PHOSPHOLIPID BILAYER;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; HUMANS; LACTOFERRIN; LACTOGLOBULINS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE;

BOVINAE;

EID: 58149105937     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.04.013     Document Type: Article

References (51)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
2. Jenssen H., Hamill P., and Hancock R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19 (2006) 491-511
3. Chan D.I., Prenner E.J., and Vogel H.J. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 1758 (2006) 1184-1202
4. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 3 (2005) 238-250
5. Stallmann H.P., Faber C., Amerongen A.V.N., and Wuisman P.I.J.M. Antimicrobial peptides: review of their application in musculoskeletal infections. Injury 37 (2006) 34-40
6. Hancock R.E.W., and Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24 (2006) 1551-1557
7. Epand R.M., and Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462 (1999) 11-28
8. Hwang P.M., and Vogel H.J. Structure-function relationships of antimicrobial peptides. Biochem. Cell Biol. 76 (1998) 235-246
9. Rink R., Wierenga J., Kuipers A., Kluskens L.D., Driessen A.J.M., Kuipers O.P., and Moll G.N. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl. Environ. Microbiol. 73 (2007) 5809-5816
10. Yuan J., Zhang Z.Z., Chen X.Z., Yang W., and Huan L.D. Site-directed mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl. Microbiol. Biotechnol. 64 (2004) 806-815
11. Pazgier M., Prahl A., Hoover D.M., and Lubkowski J. Studies of the biological properties of human beta-defensin 1. J. Biol. Chem. 282 (2007) 1819-1829
12. Hoover D.M., Wu Z.B., Tucker K., Lu W.Y., and Lubkowski J. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 47 (2003) 2804-2809
13. Ahn H.S., Cho W., Kang S.H., Ko S.S., Park M.S., Cho H., and Lee K.H. Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study. Peptides 27 (2006) 640-648
14. Valenti P., Berlutti F., Conte M.P., Longhi C., and Seganti L. Lactoferrin functions - current status and perspectives. J. Clin. Gastroenterol. 38 (2004) S127-S129
15. Tomita M., Bellamy W., Takase M., Yamauchi K., Wakabayashi H., and Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 74 (1991) 4137-4142
16. Hwang P.M., Zhou N., Shan X., Arrowsmith C.H., and Vogel H.J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37 (1998) 4288-4298
17. Bellamy W., Takase M., Wakabayashi H., Kawase K., and Tomita M. Antibacterial spectrum of lactoferricin-B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73 (1992) 472-479
18. Vorland L.H., Ulvatne H., Andersen J., Haukland H.H., Rekdal O., Svendsen J.S., and Gutteberg T.J. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand. J. Infect. Dis. 30 (1998) 513-517
19. Legrand D., Elass E., Carpentier M., and Mazurier J. Interactions of lactoferrin with cells involved in immune function. Biochem. Cell Biol. 84 (2006) 282-290
20. Japelj B., Pristovsek P., Majerle A., and Jerala R. Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J. Biol. Chem. 280 (2005) 16955-16961
21. vanBerkel P.H.C., Geerts M.E.J., vanVeen H.A., Mericskay M., deBoer H.A., and Nuijens J.H. N-terminal stretch Arg(2), Arg(3), Arg(4) and Arg(5) of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328 (1997) 145-151
22. Hunter H.N., Demcoe A.R., Jenssen H., Gutteberg T.J., and Vogel H.J. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob. Agents Chemother. 49 (2005) 3387-3395
23. Gifford J.L., Hunter H.N., and Vogel H.J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 62 (2005) 2588-2598
24. van der Kraan M.I.A., Groenink J., Nazmi K., Veerman E.C.I., Bolscher J.G.M., and Amerongen A.V.N. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25 (2004) 177-183
25. van der Kraan M.I.A., van der Made C., Nami K., Van't Hof W., Groenink J., Veerman E.C.I., Bolscher J.G.M., and Amerongen A.V.N. Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284. Peptides 26 (2005) 2093-2097
26. van der Kraan M.I.A., Nazmi K., Teeken A., Groenink J., 't Hof W., Veerman E.C.I., Bolscher J.G.M., and Amerongen A.V.N. Lactoferrampin, an antimicrobial peptide of bovine lactoferrin, exerts its candidacidal activity by a cluster of positively charged residues at the C-terminus in combination with a helix-facilitating N-terminal part. Biol. Chem. 386 (2005) 137-142
27. Haney E.F., Lau F., and Vogel H.J. Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin. Biochim. Biophys. Acta 1768 (2007) 2355-2364
28. van der Kraan M.I.A., Nazmi K., 't Hof W., Amerongen A.V.N., Veerman E.C.I., and Bolscher J.G.M. Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference. Biochem. Cell Biol. 84 (2006) 358-362
29. Fonseca N.A., Camacho R., and Magalhaes A.L. Amino acid pairing at the N- and C-termini of helical segments in proteins. Proteins 70 (2008) 188-196
30. Veerman E.C.I., Nazmi K., van Hof W., Bolscher J.G.M., den Hertog A.L., and Amerongen A.V.N. Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. Biochem. J. 381 (2004) 447-452
31. Prenner E.J., Lewis R.N.A.H., Kondejewski L.H., Hodges R.S., and McElhaney R.N. Differential scanning calorimetric study of the effect of the antimicrobial peptide gramicidin S on the thermotropic phase behavior of phosphatidylcholine, phosphatidylethanolamine and phosphatidylglycerol lipid bilayer membranes. Biochim. Biophys. Acta 1417 (1999) 211-223
32. Hwang T.L., and Shaka A.J. Water suppression that works - excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112 (1995) 275-279
33. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. Nmrpipe - a multidimensional spectral processing system based on unix pipes. J. Biomol. NMR 6 (1995) 277-293
34. Johnson B.A., and Blevins R.A. Nmr view - a computer-program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
35. Wuthrich K. NMR of Proteins and Nucleic Acids (1986), John Wiley & Sons Inc., New York
36. Guntert P., Mumenthaler C., and Wuthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273 (1997) 283-298
37. Laskowski R.A., Rullmann J.A.C., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
38. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph 14 (1996) 51
39. Lohner K. The role of membrane lipid composition in cell targeting of antimicrobial peptides. In: Lohner (Ed). Development of Novel Antimicrobial Agents: Emerging Strategies (2001), Horizon Scientific Press, Norfolk, England 149-165
40. Ramachandran G.N., Ramakrishnan C., and Sasisekharan V. Stereochemistry of polypeptide chain configurations. J. Mol. Biol. 7 (1963) 95
41. Vogel H.J., Schibli D.J., Jing W.G., Lohmeier-Vogel E.M., Epand R.F., and Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 80 (2002) 49-63
42. Xiao Y.J., Dai H., Bommineni Y.R., Soulages J.L., Gong Y.X., Prakash O., and Zhang G.L. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS J 273 (2006) 2581-2593
43. Wong H., Bowie J.H., and Carver J.A. The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida. Eur. J. Biochem. 247 (1997) 545-557
44. Pukala T.L., Brinkworth C.S., Carver J.A., and Bowie J.H. Investigating the importance of the flexible hinge in caerin 1.1: solution structures and activity of two synthetically modified caerin peptides. Biochemistry 43 (2004) 937-944
45. Yuan T., Weljie A.M., and Vogel H.J. Tryptophan fluorescence quenching by methionine and selenomethionine residues of calmodulin: orientation of peptide and protein binding. Biochemistry 37 (1998) 3187-3195
46. Andrushchenko V.V., Vogel H.J., and Prenner E.J. Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model membranes studied by differential scanning calorimetry. Biochim. Biophys. Acta 1768 (2007) 2447-2458
47. Prenner E.J., Lewis R.N.A.H., Neuman K.C., Gruner S.M., Kondejewski L.H., Hodges R.S., and McElhaney R.N. Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity. Biochemistry 36 (1997) 7906-7916
48. Klajnert B., Janiszewska J., Urbanczyk-Lipkowska Z., Bryszewska A., and Epand R.M. DSC studies on interactions between low molecular mass peptide dendrimers and model lipid membranes. Int. J. Pharm. 327 (2006) 145-152
49. Blondelle S.E., Lohner K., and Aguilar M.I. Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. Biochim. Biophys. Acta 1462 (1999) 89-108
50. Abdi M., and Drucker D.B. Phospholipid profiles in the oral yeast Candida. Arch. Oral Biol. 41 (1996) 517-522
51. Wang G.S., Li Y.F., and Li X. Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. J. Biol. Chem. 280 (2005) 5803-5811